Tryptophan Formulation for Enhanced Brain Transport

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for increasing serotonin levels in the brain, such as high protein diets or supplements, face limitations due to competition from other amino acids and stress-induced enzyme activation, which minimally increase tryptophan transport across the blood-brain barrier, and often result in unwanted side effects like increased dopamine and noradrenaline levels or storage as body fat.

Innovation Solution

A formulation combining tryptophan with tyrosine, melatonin, and specific B vitamins (B3, B6, and B12) to enhance tryptophan transport and conversion to serotonin, along with GABA to reduce stress, delivered through edible or vaporizable systems that minimize competing amino acids and insulin production to facilitate deep relaxation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If a high protein diet is provided to increase tryptophan intake, then the total amount of tryptophan ingested increases, but other amino acids also increase and compete for transport across the blood-brain barrier, minimizing the increase in serotonin production

Engineering Contradiction:
Improvetryptophan intakeVSAvoidamino acid competition at blood-brain barrier
Core Design Contradiction:
Quantity of substanceVSObject-affected harmful factors

Solution Approach 1:

The patent extracts tryptophan from its natural food matrix context and provides it as an isolated supplement, removing the competing amino acids that would otherwise be present in high protein diets. This allows tryptophan to be transported across the blood-brain barrier without competition from other amino acids.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent creates a localized condition at the blood-brain barrier by combining tryptophan with specific carbohydrates that trigger insulin release. This local metabolic change preferentially facilitates tryptophan transport across the barrier while other amino acids remain in the bloodstream.

Inventive Principle:
Principle #3Local quality

2Quantity of substance

If tryptophan supplements are provided to increase serotonin production, then serotonin levels may increase, but stress-induced activation of tryptophan metabolizing enzymes reduces tryptophan availability for brain transport

Engineering Contradiction:
Improveserotonin productionVSAvoidstress-induced enzyme activation
Core Design Contradiction:
Quantity of substanceVSObject-affected harmful factors

Solution Approach 1:

The patent applies preliminary anti-action by including Vitamin B6 in the formulation before stress occurs. Vitamin B6 inhibits the activity of tryptophan metabolizing enzymes (such as indoleamine 2,3-dioxygenase) that would otherwise be activated by stress, thereby preserving tryptophan availability for serotonin synthesis even under stress conditions.

Inventive Principle:
Principle #9Preliminary anti-action

3Ease of operation

If high carbohydrate intake is used to facilitate tryptophan transport across the blood-brain barrier, then insulin production increases to metabolize carbohydrates, but this can result in storage as body fat

Engineering Contradiction:
Improvetryptophan transport across blood-brain barrierVSAvoidbody fat storage
Core Design Contradiction:
Ease of operationVSObject-generated harmful factors

Solution Approach 1:

The patent uses a moderate amount of carbohydrate (such as dextrose or sucrose) - not excessive amounts that would definitely cause fat storage, but enough to trigger the insulin response needed to facilitate tryptophan transport. This partial action achieves the desired effect with minimal unwanted consequences.

Inventive Principle:
Principle #16Partial or excessive action

4Quantity of substance

If Vitamin B6 is added to enhance tryptophan conversion to serotonin, then serotonin production increases, but Vitamin B6 can also increase dopamine and noradrenaline levels which may have unwanted side effects

Engineering Contradiction:
Improveserotonin productionVSAvoidincreased dopamine and noradrenaline levels
Core Design Contradiction:
Quantity of substanceVSObject-generated harmful factors

Solution Approach 1:

The patent carefully controls the dosage parameter of Vitamin B6 to optimize serotonin production while minimizing the activation of dopaminergic and noradrenergic pathways. By adjusting the concentration and timing of B6 supplementation, the formulation achieves selective enhancement of serotonin synthesis.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The formulation significantly increases serotonin production in the brain, inducing a deep state of relaxation while avoiding side effects, with a delivery system that synergistically enhances tryptophan effects and is GRAS-approved to minimize regulatory issues.

Implementation Method 1

tryptophan is converted in the liver to form vitamin B3

Methodology Applied
Scientific EffectMetabolism: Fermentation

Implementation Method 2

the blood brain barrier (BBB). While the BBB primarily serves to prevent toxins from entering the brain, it also serves to limit transport of amino acids, such as tryptophan, into the brain

Methodology Applied
Scientific EffectBlood-brain barrier transport limitation: Semipermeable Membrane

Implementation Method 3

the insulin has the further effect of clearing a significant amount of amino acids present in the food source from the person's blood stream

Methodology Applied
Scientific EffectInsulin-mediated amino acid clearance:

Implementation Method 4

the only serotonin available for use by the brain must be produced internally or converted from tryptophan, or its intermediate, which have crossed the BBB

Methodology Applied
Scientific EffectEnzymatic conversion: Enzyme

Data Source

PatentUS9040582B2Formulation and method to induce a deep state of relaxation
Publication Date: 2015.05.26 KELLER RAYMOND M

AI summary

A relaxation formulation structured to induce a deep state of relaxation in a person comprises amounts of tryptophan, melatonin, vitamin B3, and vitamin B6. Another relaxation formulation also includes an amount of tyrosine, and yet another formulation includes an amount of vitamin B12. At least one embodiment of a relaxation formula comprises a physiologically effective amount of gamma-aminobutyric acid (“GABA”). A delivery system is provided to facilitate administration of the relaxation formulation to a person. The delivery system may include an edible high carbohydrate matrix, such as a chocolate brownie. Alternatively, the delivery system may comprise an inert vaporizable compound to allow the components of the relaxation formulation to be inhaled directly into the lungs of a person. Other delivery systems include an aqueous sublingual spray and a beverage.